Aytu Biopharma, Inc.股价重挫14.67% 市值跌200.04万美元

市场透视2025-05-16

北京时间2025年05月16日21时32分，Aytu Biopharma, Inc.（AYTU.us）股票出现异动，股价快速跳水14.67%。截至发稿，该股报2.21美元/股，成交量61.5911万股，换手率9.98%，振幅5.79%。最近的财报数据显示，该股实现营业收入18.45百万美元，净利润3.94百万美元，每股收益0.65美元，毛利11.89百万美元，市盈率-3.10倍。机构评级方面，目前...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2535134303?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-16 21:32","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2535134303","market":"us","top_or_hot":-1,"title":"Aytu Biopharma, Inc.股价重挫14.67% 市值跌200.04万美元","media":"市场透视","content":"<div>\n<p>北京时间2025年05月16日21时32分，Aytu Biopharma, Inc.（AYTU.us）股票出现异动，股价快速跳水14.67%。截至发稿，该股报2.21美元/股，成交量61.5911万股，换手率9.98%，振幅5.79%。最近的财报数据显示，该股实现营业收入18.45百万美元，净利润3.94百万美元，每股收益0.65美元，毛利11.89百万美元，市盈率-3.10倍。机构评级方面，目前...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516213241a480f7ed&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Aytu Biopharma, Inc.股价重挫14.67% 市值跌200.04万美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAytu Biopharma, Inc.股价重挫14.67% 市值跌200.04万美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-16 21:32 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516213241a480f7ed&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年05月16日21时32分，Aytu Biopharma, Inc.（AYTU.us）股票出现异动，股价快速跳水14.67%。截至发稿，该股报2.21美元/股，成交量61.5911万股，换手率9.98%，振幅5.79%。最近的财报数据显示，该股实现营业收入18.45百万美元，净利润3.94百万美元，每股收益0.65美元，毛利11.89百万美元，市盈率-3.10倍。机构评级方面，目前...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516213241a480f7ed&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516213241a480f7ed&s=b","article_id":"2535134303","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516213241a480f7ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2535134303","pubTimestamp":1747402360,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年05月16日21时32分，Aytu Biopharma, Inc.股票出现异动，股价快速跳水14.67%。Aytu Biopharma, Inc.股票所在的制药行业中，整体涨幅为0.55%。其相关个股中，Biofrontera Inc C/Wts 27/10/2026 、Incannex Healthcare Inc.、Emergent Biosolutions Inc.涨幅较大，Incannex Healthcare Inc.、Petros Pharmaceuticals, Inc.、Aytu Biopharma, Inc.较为活跃，换手率分别为503.23%、95.68%、10.08%，振幅较大的相关个股有Incannex Healthcare Inc.、Petros Pharmaceuticals, Inc.、Gelteq Limited，振幅分别为11.25%、7.50%、6.37%。Aytu Biopharma, Inc.公司简介：Aytu BioPharma Inc 是一家专业制药公司，拥有处方疗法和消费者健康产品的商业组合。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4007":"制药","AYTU":"Aytu BioScience, Inc."},"translate_title":"Aytu Biopharma, Inc. 's stock plunges 14.67%, its market value falls by $2,000,400","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AYTU":0.9},"content_text":"北京时间2025年05月16日21时32分，Aytu Biopharma, Inc.（AYTU.us）股票出现异动，股价快速跳水14.67%。截至发稿，该股报2.21美元/股，成交量61.5911万股，换手率9.98%，振幅5.79%。最近的财报数据显示，该股实现营业收入18.45百万美元，净利润3.94百万美元，每股收益0.65美元，毛利11.89百万美元，市盈率-3.10倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Aytu Biopharma, Inc.股票所在的制药行业中，整体涨幅为0.55%。其相关个股中，Biofrontera Inc C/Wts 27/10/2026 (To Pur Com)、Incannex Healthcare Inc.、Emergent Biosolutions Inc.涨幅较大，Incannex Healthcare Inc.、Petros Pharmaceuticals, Inc.、Aytu Biopharma, Inc.较为活跃，换手率分别为503.23%、95.68%、10.08%，振幅较大的相关个股有Incannex Healthcare Inc.、Petros Pharmaceuticals, Inc.、Gelteq Limited，振幅分别为11.25%、7.50%、6.37%。Aytu Biopharma, Inc.公司简介：Aytu BioPharma Inc 是一家专业制药公司，拥有处方疗法和消费者健康产品的商业组合。该公司的主要处方产品用于治疗注意力缺陷多动障碍和其他常见的儿科疾病。它正在建立一个互补的治疗开发渠道，包括一种针对血管性埃勒斯-当洛斯综合征的前瞻性治疗（AR101/enzastaurin），这是一种罕见的遗传病，导致高发病率和显着缩短的寿命。该公司在两个部门运营：Rx 部门（包括处方药产品）和消费者健康部门，其中公司从 Rx 部门获得最大收入。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2535134303","isCrawlerRequest":true}